United States: Impact Of Incomplete Notice Of Prior Art

The International Trade Commission (ITC) continues to be a popular venue for enforcing intellectual property rights through Section 337 investigations due, in part, to the fast pace at which the investigations are completed, with most lasting about 16 months. This fast pace has its pit falls, however. If a respondent at the ITC fails to gather and disclose the prior art it needs in a timely manner, the respondent may be precluded from relying on any prior art not identified in its notice unless the respondent can show good cause. In fact, the Administrative Law Judge (ALJ) in Certain Reduced Folate Nutraceutical Products and L-Methylfolate Raw Ingredients Used Therein (Certain Reduced Folate Nutraceutical Products), Inv. No. 337-TA-857, recently denied the respondents' motion to supplement their notice of prior art for failing to establish good cause for supplementation.

In Section 337 proceedings, discovery is typically concluded in four to six months; in contrast, discovery in a district court case may last one to two years. Many ALJs at the ITC set an early deadline for a respondent to provide a notice of prior art on which it intends to rely, usually within two to three months after the investigation is instituted. This time frame is similar to that of district courts having local patent rules which require disclosure of prior art through a defendant's invalidity contentions. In district courts without local patent rules, 35 U.S.C. § 282(c) requires only that a notice of prior art be filed "at least thirty days before the trial."

In Certain Reduced Folate Nutraceutical Products, Respondents Macoven Pharmaceuticals, LLC and Viva Pharmaceuticals, Inc. (collectively, Respondents) filed a motion seeking leave to submit a supplemental Notice of Prior Art adding U.S. Patent No. 6,008,221 (the'221 Patent) approximately one month after the Notice of Prior Art deadline in the procedural schedule. Respondents argued that good cause to supplement their Notice of Prior Art existed because (1) Complainants South Alabama Medical Science Foundation, Merck and Cie, and Pamlab LLC (collectively, Complainants) failed to identify the '221 Patent in their response to Respondents' interrogatory seeking the identity of all prior art to the asserted patent; (2) the '221 Patent was buried among thousands of documents that Complainants produced in discovery; and (3) Complainants failed to identify the '221 Patent in the asserted patent's reexamination proceeding at the USPTO until after Respondents identified the reference. Respondents further asserted that it is in the public interest to fully assess the validity of a patent and that Complainants would not be prejudiced by the addition as there was sufficient time before the exchange of expert reports and the hearing.

Complainants opposed the motion and argued that Respondents failed to show good cause warranting the supplementation. Complainants claimed that Respondents' argument that Complainants failed to disclose the '221 Patent in the asserted patent's reexamination proceeding was a red herring. Finally, Complainants asserted that any supplementation would be prejudicial to Complainants and the procedural schedule would be compromised.

ALJ Essex denied Respondents' motion for leave to supplement their notice of prior art and found no good cause because Respondents failed to show why they could not have found the '221 Patent earlier by simply conducting a prior art search at the USPTO. The ALJ's Order is available online. ALJ Essex determined that the '221 Patent is not an obscure piece of prior art and that both the '221 Patent and the asserted patent share the same prior art classes. Thus, ALJ Essex reasoned that any rational prior art searcher should have searched the asserted patent's prior art classes and would have come across the '221 Patent. Notably, however, ALJ Essex specifically stated that he may have reached a different conclusion if there was some difficulty in locating the '221 Patent, for example if the '221 Patent were a foreign patent, an article, a prior use, or in a foreign language. Accordingly, in the absence of any special reason why a reasonable prior art search would not have uncovered the '221 Patent, ALJ Essex found that there was no good cause for supplementation and denied Respondents' motion.

Practice Tips:

  • ITC respondents face the challenge of collecting and reviewing all available public prior art that they can find by the time of their prior art notice, which will likely be due just two to three months into the investigation. A respondent that is unprepared, or fails to start developing its invalidity case immediately upon notice of the investigation, risks potentially devastating preclusion of relevant prior art.
  • Parties should be prepared to spend the time and money on exhaustive prior art searches early in the investigation because ALJs may take a narrow view of the "good cause" needed to amend this notice after the deadline set in the procedural schedule.
  • Respondents should also be careful to refine their prior art notice to only include references that will be used in the investigation as ALJs have stricken notices of prior art for being too voluminous and thus failing to provide sufficient notice to the other parties.

Below please find other examples of notice of prior art decisions issued in Section 337 proceedings:

  • Inv. No. 337-TA-794, Certain Elec. Devices, Including Wireless Commc'n Devices, Portable Music and Data Processing Devices, and Tablet Computers, Order No. 40 – Complainants filed a motion to strike Respondent's notice of prior art which included over 7,000 entries on 380 pages. The Commission Investigative Staff opposed the motion to strike, but recommended that Respondent should be required to file an amended Notice of Prior Art that contained only the references that Respondent planned to rely on at the hearing. The ALJ granted the motion to strike, reasoning the voluminous notice of prior art provided "no notice at all" for Complainants. The ALJ allowed Respondent to re-file its notice of prior art because Complainants improperly withheld their priority date disclosures, but the ALJ noted that Respondent could only include references that appeared in its original notice.

    The ALJ's Order is available online.
  • Inv. No. 337-TA-790, Certain Coenzyme Q10 Prods. and Methods of Making Same, Order No. 21 – Respondents filed a motion to supplement their notice of prior art to include a newly discovered reference. Respondents argued that good cause existed because the prior art reference, although publicly available, was published in a relatively obscure journal. The ALJ denied the motion to supplement the prior art notice, relying on a prior warning to all counsel at the preliminary conference that "the fact that your expert couldn't find the references is not adequate for good cause."

    The ALJ's Order is available online.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Alice Alexandra Kipel
Similar Articles
Relevancy Powered by MondaqAI
McDermott Will & Emery
 
In association with
Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
McDermott Will & Emery
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions